Decipher Labs Limited (DECIPHER) Share Price

BSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE643N01012

₹5.75-0.10 (-1.71%)

Key metrics

Market Cap
₹6 Cr
P/E Ratio
EPS
-3.05
Book Value
20.46
P/B Ratio
0.28
ROE
-14.93%
ROCE
-18.45%
Debt / Equity
0.02
Net Margin
-21.95%
Revenue Growth
-37.85%
Profit Growth
39.29%
Dividend Yield
52W High
₹11.38
52W Low
₹5.00
Market Cap Band
micro cap
Face Value

Ratios computed from the annual results period ending 2026-03-31.

About Decipher Labs Limited

Decipher Labs Limited, together with its subsidiaries, manufactures, markets, sells, and trades in pharmaceutical drugs in India and internationally. It operates through two segments, Manufacturing and Trading of Pharmaceutical Drugs and Consultancy. The company offers branded and finished formulations, bulk drugs, and chemicals. It also provides information technology (IT) consultancy services comprising technology integration and systems consulting, software development consulting, and management of IT projects. In addition, the company offers ERP implementation, mobile and cloud solutions, product development, and offshore services. It serves formulators, manufacturers, and research and development agencies. The company was formerly known as Combat Drugs Limited and changed its name to Decipher Labs Limited in January 2020. Decipher Labs Limited was incorporated in 1986 and is based in Hyderabad, India.

Headquarters
Hyderabad, India
Promoter Holding
27.41%

The full Decipher Labs Limited analysis

Create a free account to open the complete DECIPHER deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.

  • 10-year financialsIncome statement, balance sheet and cash flow, year by year.
  • Valuation & fair valueFair-value estimates, quality scores and a value grade.
  • Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
  • Shareholding historyPromoter, FII, DII and public holdings across every quarter.
  • Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
  • Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.